Clinical trial

Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM)

NCT01275131

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-01-01

PhasePHASE1

Study timeline

Study start (unknown)2011-01-01Date precision: month

Registry last updated2014-07-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetes Mellitusunresolved

Interventions

Insulin aspartDRUG

Recombinant human hyaluronidase PH20 (rHuPH20)DRUG

Sponsors & collaborators

Halozyme Therapeuticslead sponsor

Mapped research locations

Chula VistaCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01275131 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.